Next-ChemX Corp(CHMX)
$0.010.00 (0.00%)
CHMX
Next-ChemX Corp financials statements
$0.01
At close:0.00 (0.00%)
Next-ChemX Corp (CHMX) Ratios
6 Followers
Next-ChemX Corp Ratios
CHMX's free cash flow for Q2 2025 was $-330.17K. For the 2025 fiscal year, CHMX's free cash flow was increased by $5.00 and operating cash flow was $-330.17K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.15 | 0.04 | 0.02 | 0.01 | 0.23 |
| Quick Ratio | 0.15 | 0.04 | 0.02 | 0.01 | 0.23 |
| Cash Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.22 |
| Solvency Ratio | -0.27 | -0.60 | -0.70 | -0.97 | 2.30 |
| Operating Cash Flow Ratio | -0.34 | -0.14 | -0.38 | -0.48 | 0.91 |
| Short-Term Operating Cash Flow Coverage | -1.81 | -0.58 | -1.01 | -1.01 | 0.00 |
| Net Current Asset Value | $ -5.45M | $ -3.79M | $ -2.44M | $ -1.46M | $ -154.41K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.75 | 0.29 | 0.29 | 0.22 | 0.00 |
| Debt-to-Equity Ratio | -0.84 | -0.87 | 1.27 | 0.40 | 0.00 |
| Debt-to-Capital Ratio | -5.15 | -6.63 | 0.56 | 0.29 | 0.00 |
| Long-Term Debt-to-Capital Ratio | -1.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.12 | -3.04 | 4.40 | 1.86 | -0.30 |
| Debt Service Coverage Ratio | -1.53 | -2.40 | -1.67 | -1.95 | 1.37 |
| Interest Coverage Ratio | -9.29 | 0.00 | -23.73 | -52.95 | -556.60 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.09 | 0.03 | 0.04 | 0.03 | 0.00 |
| Net Debt to EBITDA | -1.50 | -0.42 | -0.54 | -0.48 | -153.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | -292.41% |
| EBT Per EBIT | 104.55% | 119.42% | 104.24% | 100.96% | 100.00% |
| Return on Assets (ROA) | -55.73% | -71.48% | -54.19% | -56.04% | 737.90% |
| Return on Equity (ROE) | 62.51% | 217.10% | -238.29% | -104.18% | -223.47% |
| Return on Capital Employed (ROCE) | 131.76% | 314.13% | -228.59% | -103.18% | 76.42% |
| Return on Invested Capital (ROIC) | 367.75% | -626.35% | -100.91% | -73.44% | 76.42% |
| Return on Tangible Assets | -254.51% | -1543.66% | -2546.69% | -5314.43% | 737.90% |
| Earnings Yield | -1.63% | -1.18% | -0.57% | -0.92% | 0.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -7339.82 | -167123.42 | -109552.34 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 7339.82 | 167123.42 | 109552.34 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.02 | -0.03 | -0.03 | 0.02 |
| Free Cash Flow Per Share | -0.05 | -0.02 | -0.03 | -0.03 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -592.95 | -29.25 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -592.95 | -29.25 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.63 | -0.58 | -1.01 | -1.01 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1.37% | -0.27% | -0.31% | -0.37% | 0.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -61.53 | -84.40 | -175.36 | -108.85 | 127.21 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -38.46 | -183.23 | 417.86 | 113.40 | -284.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -72.81 | -365.71 | -326.50 | -266.90 | 239.21 |
| Price-to-Operating Cash Flow Ratio | -72.81 | -365.71 | -327.05 | -276.02 | 239.21 |
| Price-to-Earnings Growth (PEG) Ratio | 2.64 | -3.13 | 7.75 | 0.34 | -0.37 |
| Enterprise Value Multiple | -72.14 | -88.28 | -183.88 | -137.82 | 150685.85 |
| Enterprise Value | 113.98M | 200.21M | 306.72M | 194.88M | 43.85M |
| EV to EBITDA | -72.14 | -88.28 | -183.88 | -137.82 | 150685.85 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -74.36 | -367.43 | -327.46 | -267.84 | 238.97 |
| EV to Operating Cash Flow | -74.36 | -367.43 | -328.01 | -276.99 | 238.97 |
| Tangible Book Value Per Share | -0.19 | -0.13 | -0.09 | -0.07 | -0.02 |
| Shareholders’ Equity Per Share | -0.10 | -0.04 | 0.03 | 0.08 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.06 | -0.08 | -0.06 | -0.08 | 0.04 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | -2.92 |
| Interest Burden | 1.05 | 0.97 | 1.04 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.84 | 0.23 | 0.54 | 0.39 | 0.23 |
Currency in USD
